Tae Heum Um

Title: Tae Heum Um: Innovator in Ophthalmic Preparations

Introduction

Tae Heum Um is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized external preparations and ophthalmic formulations. With a total of 2 patents, his work focuses on enhancing the stability and efficacy of thymosin beta 4.

Latest Patents

Tae Heum Um's latest patents include a "Stabilized external preparation comprising thymosin beta 4 as an active ingredient." This invention relates to a therapeutically effective external preparation that improves the stability and biological activity of thymosin beta 4. The preparation maintains thymosin beta 4 in a stable state while minimizing the generation of sulfoxide and multimers through oxidation reactions and aggregation. Another significant patent is the "Method for preparing ophthalmic preparation containing thymosin beta-4." This method involves manufacturing an ophthalmic preparation in the presence of an inert gas, which prevents the oxidation of thymosin beta 4 and ensures its pharmacological activity is maintained over a long period.

Career Highlights

Throughout his career, Tae Heum Um has worked with various companies, including G-treebnt Co., Ltd. and HLB Therapeutics Co., Ltd. His innovative approaches have contributed to advancements in therapeutic preparations, particularly in ophthalmology.

Collaborations

Tae Heum Um has collaborated with notable coworkers such as Si Young Lee and Jun Won Choi. Their combined expertise has likely enhanced the development of his innovative products.

Conclusion

Tae Heum Um is a distinguished inventor whose work in ophthalmic preparations and stabilized external formulations has made a significant impact in the pharmaceutical industry. His patents reflect a commitment to improving therapeutic efficacy and stability, showcasing his role as a key innovator in his field.